The majority of rheumatoid arthritis (RA) synovial fluid lymphocytes (SFL) demonstrate markers that are suggestive of prior activation. While the mechanism(s) responsible is unknown, prior studies have suggested that certain Mycobacterium tuberculosis (MT) antigens may preferentially activate SFL in vitro. We therefore examined the ability of RA SFL to respond to purified protein derivative and an acetone‐precipitable MT antigenic complex (AP‐MT) and compared this with the responses by peripheral blood lymphocytes (PBL). The responses were contrasted with those elicited with tetanus toxoid (TT) and mitogenic anti‐CD3. In patients with RA, the SF proliferative responses to both TT and anti‐CD3 were reduced compared with responses by PB. In contrast, the SF response to purified protein derivative was maintained, and that to AP‐MT was significantly increased, compared with PB. SF responses to AP‐MT antigens were significantly greater than those to TT. The AP‐MT activation of T lymphocytes from RA SF was characterized by an earlier peak proliferative response than that noted with matched PB. AP‐MT responsiveness was not restricted to HLA–DR4 positive patients. These observations suggest that an epitope(s) contained within the MT complex of antigens, and enriched in the AP‐MT complex, may be important in maintaining the chronic inflammation in at least some patients with RA.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.